Inherited genetic susceptibility to breast cancer: The beginning of the end or the end of the beginning?

American Journal of Pathology

Volumn 183, Issue 4, 2013, Pages 1038-1051

  Ghoussaini, Maya ^a   Pharoah, Paul D P ^a   Easton, Douglas F ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CYCLIN D1; ESTROGEN; FIBROBLAST GROWTH FACTOR RECEPTOR 2;

AGGRESSIVENESS; APOPTOSIS; BREAST CANCER; BREAST CARCINOGENESIS; CANCER PREVENTION; CANCER SCREENING; CELL DIFFERENTIATION; DNA REPAIR; GENE FREQUENCY; GENE LOCUS; GENE MAPPING; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC SUSCEPTIBILITY; HUMAN; INHERITANCE; LINKAGE ANALYSIS; MOLECULAR GENETICS; NONHUMAN; PENETRANCE; PERSONALIZED MEDICINE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; REVIEW; TELOMERE HOMEOSTASIS; TUMOR SUPPRESSOR GENE; WNT SIGNALING PATHWAY;

ALLELES; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PENETRANCE; SIGNAL TRANSDUCTION;

EID: 84884582201     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.07.003     Document Type: Review

References (104)

1. F. Kamangar, G.M. Dores, and W.F. Anderson Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world J Clin Oncol 24 2006 2137 2150
2. T. Wright, and A. McGechan Breast cancer: new technologies for risk assessment and diagnosis Mol Diagn 7 2003 49 55
3. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease Lancet 358 2001 1389 1399
4. D.E. Goldgar, D.F. Easton, L.A. Cannon-Albright, and M.H. Skolnick Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands J Natl Cancer Inst 86 1994 1600 1608
5. P. Lichtenstein, N.V. Holm, P.K. Verkasalo, A. Iliadou, J. Kaprio, M. Koskenvuo, E. Pukkala, A. Skytthe, and K. Hemminki Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland N Engl J Med 343 2000 78 85
6. J. Peto, and T.M. Mack High constant incidence in twins and other relatives of women with breast cancer Nat Genet 26 2000 411 414
7. Y. Miki, J. Swensen, D. Shattuck-Eidens, P.A. Futreal, K. Harshman, and S. Tavtigian A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 1994 66 71
8. R. Wooster, G. Bignell, J. Lancaster, S. Swift, S. Seal, J. Mangion, N. Collins, S. Gregory, C. Gumbs, and G. Micklem Identification of the breast cancer susceptibility gene BRCA2 Nature 378 1995 789 792
9. A.C. Antoniou, A.P. Cunningham, J. Peto, D.G. Evans, F. Lalloo, S.A. Narod, H.A. Risch, J.E. Eyfjord, J.L. Hopper, M.C. Southey, H. Olsson, O. Johannsson, A. Borg, B. Pasini, P. Radice, S. Manoukian, D.M. Eccles, N. Tang, E. Olah, H. Anton-Culver, E. Warner, J. Lubinski, J. Gronwald, B. Gorski, L. Tryggvadottir, K. Syrjakoski, O.P. Kallioniemi, H. Eerola, H. Nevanlinna, P.D. Pharoah, and D.F. Easton The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions Br J Cancer 98 2008 1457 1466
10. A. Antoniou, P.D. Pharoah, S. Narod, H.A. Risch, J.E. Eyfjord, J.L. Hopper, N. Loman, H. Olsson, O. Johannsson, A. Borg, B. Pasini, P. Radice, S. Manoukian, D.M. Eccles, N. Tang, E. Olah, H. Anton-Culver, E. Warner, J. Lubinski, J. Gronwald, B. Gorski, H. Tulinius, S. Thorlacius, H. Eerola, H. Nevanlinna, K. Syrjakoski, O.P. Kallioniemi, D. Thompson, C. Evans, J. Peto, F. Lalloo, D.G. Evans, and D.F. Easton Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 2003 1117 1130
11. M.C. King, J.H. Marks, and J.B. Mandell Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 Science 302 2003 643 646
12. D. Malkin, F.P. Li, L.C. Strong, J.F. Fraumeni Jr., C.E. Nelson, D.H. Kim, J. Kassel, M.A. Gryka, F.Z. Bischoff, M.A. Tainsky, and S. Friend Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms Science 250 1990 1233 1238
13. A. Hemminki, D. Markie, I. Tomlinson, E. Avizienyte, S. Roth, A. Loukola, G. Bignell, W. Warren, M. Aminoff, P. Hoglund, H. Jarvinen, P. Kristo, K. Pelin, M. Ridanpaa, R. Salovaara, T. Toro, W. Bodmer, S. Olschwang, A.S. Olsen, M.R. Stratton, A. de la Chapelle, and L.A. Aaltonen A serine/threonine kinase gene defective in Peutz-Jeghers syndrome Nature 391 1998 184 187
14. A. Renwick, D. Thompson, S. Seal, P. Kelly, T. Chagtai, M. Ahmed, B. North, H. Jayatilake, R. Barfoot, K. Spanova, L. McGuffog, D.G. Evans, D. Eccles, D.F. Easton, M.R. Stratton, and N. Rahman ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles Nat Genet 38 2006 873 875
15. D.W. Bell, J.M. Varley, T.E. Szydlo, D.H. Kang, D.C. Wahrer, K.E. Shannon, M. Lubratovich, S.J. Verselis, K.J. Isselbacher, J.F. Fraumeni, J.M. Birch, F.P. Li, J.E. Garber, and D.A. Haber Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome Science 286 1999 2528 2531
16. H. Meijers-Heijboer, A. van den Ouweland, J. Klijn, M. Wasielewski, A. de Snoo, and R. Oldenburg CHEK2-Breast Cancer Consortium: Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations Nat Genet 31 2002 55 59
17. N. Rahman, S. Seal, D. Thompson, P. Kelly, A. Renwick, A. Elliott, S. Reid, K. Spanova, R. Barfoot, T. Chagtai, H. Jayatilake, L. McGuffog, S. Hanks, D.G. Evans, D. Eccles, D.F. Easton, and M.R. Stratton PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene Nat Genet 39 2007 165 167
18. S. Seal, D. Thompson, A. Renwick, A. Elliott, P. Kelly, R. Barfoot, T. Chagtai, H. Jayatilake, M. Ahmed, K. Spanova, B. North, L. McGuffog, D.G. Evans, D. Eccles, D.F. Easton, M.R. Stratton, and N. Rahman Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles Nat Genet 38 2006 1239 1241
19. M.R. Nelen, G.W. Padberg, E.A. Peeters, A.Y. Lin, B. van den Helm, R.R. Frants, V. Coulon, A.M. Goldstein, M.M. van Reen, D.F. Easton, R.A. Eeles, S. Hodgsen, J.J. Mulvihill, V.A. Murday, M.A. Tucker, E.C. Mariman, T.M. Starink, B.A. Ponder, H.H. Ropers, H. Kremer, M. Longy, and C. Eng Localization of the gene for Cowden disease to chromosome 10q22-23 Nat Genet 13 1996 114 116
20. P. Guilford, J. Hopkins, J. Harraway, M. McLeod, N. McLeod, P. Harawira, H. Taite, R. Scoular, A. Miller, and A.E. Reeve E-cadherin germline mutations in familial gastric cancer Nature 392 1998 402 405
21. D.F. Easton How many more breast cancer predisposition genes are there? Breast Cancer Res 1 1999 14 17
22. P.D. Pharoah, J. Tyrer, A.M. Dunning, D.F. Easton, and B.A. Ponder Association between common variation in 120 candidate genes and breast cancer risk PLoS Genet 3 2007 e42
23. A. Cox, A.M. Dunning, M. Garcia-Closas, S. Balasubramanian, M.W. Reed, and K.A. Pooley A common coding variant in CASP8 is associated with breast cancer risk Nat Genet 39 2007 352 358
24. S. Ahmed, G. Thomas, M. Ghoussaini, C.S. Healey, M.K. Humphreys, and R. Platte Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 Nat Genet 41 2009 585 590
25. A.C. Antoniou, X. Wang, Z.S. Fredericksen, L. McGuffog, R. Tarrell, and O.M. Sinilnikova A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population Nat Genet 42 2010 885 892
26. D.F. Easton, K.A. Pooley, A.M. Dunning, P.D. Pharoah, D. Thompson, and D.G. Ballinger Genome-wide association study identifies novel breast cancer susceptibility loci Nature 447 2007 1087 1093
27. M. Ghoussaini, O. Fletcher, K. Michailidou, C. Turnbull, M.K. Schmidt, and E. Dicks Genome-wide association analysis identifies three new breast cancer susceptibility loci Nat Genet 44 2012 312 318
28. C.A. Haiman, G.K. Chen, C.M. Vachon, F. Canzian, A. Dunning, and R.C. Millikan A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer Nat Genet 43 2011 1210 1214
29. D.J. Hunter, P. Kraft, K.B. Jacobs, D.G. Cox, M. Yeager, S.E. Hankinson, S. Wacholder, Z. Wang, R. Welch, A. Hutchinson, J. Wang, K. Yu, N. Chatterjee, N. Orr, W.C. Willett, G.A. Colditz, R.G. Ziegler, C.D. Berg, S.S. Buys, C.A. McCarty, H.S. Feigelson, E.E. Calle, M.J. Thun, R.B. Hayes, M. Tucker, D.S. Gerhard, J.F. Fraumeni Jr., R.N. Hoover, G. Thomas, and S.J. Chanock A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer Nat Genet 39 2007 870 874
30. S.N. Stacey, A. Manolescu, P. Sulem, T. Rafnar, J. Gudmundsson, and S.A. Gudjonsson Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer Nat Genet 39 2007 865 869
31. S.N. Stacey, A. Manolescu, P. Sulem, S. Thorlacius, S.A. Gudjonsson, and G.F. Jonsson Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer Nat Genet 40 2008 703 706
32. C. Turnbull, S. Ahmed, J. Morrison, D. Pernet, A. Renwick, M. Maranian, S. Seal, M. Ghoussaini, S. Hines, C.S. Healey, D. Hughes, M. Warren-Perry, W. Tapper, D. Eccles, D.G. Evans, M. Hooning, M. Schutte, A. van den Ouweland, R. Houlston, G. Ross, C. Langford, P.D. Pharoah, M.R. Stratton, A.M. Dunning, N. Rahman, and D.F. Easton Genome-wide association study identifies five new breast cancer susceptibility loci Nat Genet 42 2010 504 507
33. W. Zheng, J. Long, Y.T. Gao, C. Li, Y. Zheng, Y.B. Xiang, W. Wen, S. Levy, S.L. Deming, J.L. Haines, K. Gu, A.M. Fair, Q. Cai, W. Lu, and X.O. Shu Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1 Nat Genet 41 2009 324 328
34. M. Garcia-Closas, F.J. Couch, S. Lindstrom, K. Michailidou, M.K. Schmidt, and M.N. Brook Genome-wide association studies identify four ER negative-specific breast cancer risk loci Nat Genet 45 2013 392
35. K. Michailidou, P. Hall, A. Gonzalez-Neira, M. Ghoussaini, J. Dennis, and R.L. Milne Large-scale genotyping identifies 41 new loci associated with breast cancer risk Nat Genet 45 2013 353 361 361e1-2
36. A. Siddiq, F.J. Couch, G.K. Chen, S. Lindstrom, D. Eccles, and R.C. Millikan A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11 Hum Mol Genet 21 2012 5373 5384
37. S.R. Lakhani, M.J. van de Vijver, J. Jacquemier, T.J. Anderson, P.P. Osin, L. McGuffog, and D.F. Easton The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2 J Clin Oncol 20 2002 2310 2318
38. A.C. Antoniou, A.B. Spurdle, O.M. Sinilnikova, S. Healey, K.A. Pooley, and R.K. Schmutzler Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers Am J Hum Genet 82 2008 937 948
39. A.C. Antoniou, J. Beesley, L. McGuffog, O.M. Sinilnikova, S. Healey, and S.L. Neuhausen Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction Cancer Res 70 2010 9742 9754
40. M. Garcia-Closas, P. Hall, H. Nevanlinna, K. Pooley, J. Morrison, D.A. Richesson Australian Ovarian Cancer Management Group, Kathleen Cuningham Foundation Consortium For Research Into Familial Breast Cancer Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics PLoS Genet 4 2008 e1000054
41. M. Garcia-Closas, and S. Chanock Genetic susceptibility loci for breast cancer by estrogen receptor status Clin Cancer Res 14 2008 8000 8009
42. P.J. Stephens, P.S. Tarpey, H. Davies, L.P. Van, C. Greenman, and D.C. Wedge The landscape of cancer genes and mutational processes in breast cancer Nature 486 2012 400 404
43. Z. Xu, and J.A. Taylor SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies Nucleic Acids Res 37 2009 W600 W605
44. I. Dunham, A. Kundaje, S.F. Aldred, P.J. Collins, C.A. Davis, and F. Doyle An integrated encyclopedia of DNA elements in the human genome Nature 489 2012 57 74
45. K.B. Meyer, A.T. Maia, M. O'Reilly, A.E. Teschendorff, S.F. Chin, C. Caldas, and B.A. Ponder Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer PLoS Biol 6 2008 e108
46. J.D. French, M. Ghoussaini, S.L. Edwards, K.B. Meyer, K. Michailidou, and S. Ahmed Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers Am J Hum Genet 92 2013 489 503
47. M.S. Udler, K.B. Meyer, K.A. Pooley, E. Karlins, J.P. Struewing, J. Zhang, D.R. Doody, S. Macarthur, J. Tyrer, P.D. Pharoah, R. Luben, L. Bernstein, L.N. Kolonel, B.E. Henderson, M.L. Le, G. Ursin, M.F. Press, P. Brennan, S. Sangrajrang, V. Gaborieau, F. Odefrey, C.Y. Shen, P.E. Wu, H.C. Wang, D. Kang, K.Y. Yoo, D.Y. Noh, S.H. Ahn, B.A. Ponder, C.A. Haiman, K.E. Malone, A.M. Dunning, E.A. Ostrander, and D.F. Easton FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation Hum Mol Genet 18 2009 1692 1703
48. M.S. Udler, J. Tyrer, and D.F. Easton Evaluating the power to discriminate between highly correlated SNPs in genetic association studies Genet Epidemiol 34 2010 463 468
49. S.E. Bojesen, K.A. Pooley, S.E. Johnatty, J. Beesley, K. Michailidou, and J.P. Tyrer Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer Nat Genet 45 2013 371 372
50. F. Chen, G.K. Chen, R.C. Millikan, E.M. John, C.B. Ambrosone, L. Bernstein, W. Zheng, J.J. Hu, R.G. Ziegler, S.L. Deming, E.V. Bandera, S. Nyante, J.R. Palmer, T.R. Rebbeck, S.A. Ingles, M.F. Press, J.L. Rodriguez-Gil, S.J. Chanock, M.L. Le, L.N. Kolonel, B.E. Henderson, D.O. Stram, and C.A. Haiman Fine-mapping of breast cancer susceptibility loci characterizes genetic risk in African Americans Hum Mol Genet 20 2011 4491 4503
51. P.E. Huijts, M. van Dongen, M.C. de Goeij, A.J. van Moolenbroek, F. Blanken, M.P. Vreeswijk, E.M. de Kruijf, W.E. Mesker, E.W. van Zwet, R.A. Tollenaar, V.T. Smit, C.J. van Asperen, and P. Devilee Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10 Breast Cancer Res 13 2011 R72
52. M.S. Udler, S. Ahmed, C.S. Healey, K. Meyer, J. Struewing, and M. Maranian Fine scale mapping of the breast cancer 16q12 locus Hum Mol Genet 19 2010 2507 2515
53. J. Long, Q. Cai, X.O. Shu, S. Qu, C. Li, and Y. Zheng Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium PLoS Genet 6 2010 e1001002
54. L.R. Cowper-Sal, X. Zhang, J.B. Wright, S.D. Bailey, M.D. Cole, J. Eeckhoute, J.H. Moore, and M. Lupien Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression Nat Genet 44 2012 1191 1198
55. A.C. Pond, X. Bin, T. Batts, K. Roarty, S. Hilsenbeck, and J.M. Rosen Fibroblast growth factor receptor signaling is essential for normal mammary gland development and stem cell function Stem Cells 31 2013 178 189
56. J. Adnane, P. Gaudray, C.A. Dionne, G. Crumley, M. Jaye, J. Schlessinger, P. Jeanteur, D. Birnbaum, and C. Theillet BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers Oncogene 6 1991 659 663
57. A.B. Moffa, S.L. Tannheimer, and S.P. Ethier Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells Mol Cancer Res 2 2004 643 652
58. J.J. Wysolmerski, and A.E. Broadus Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein Annu Rev Med 45 1994 189 200
59. M. Lomnytska, A. Dubrovska, U. Hellman, N. Volodko, and S. Souchelnytskyi Increased expression of cSHMT, Tbx3 and utrophin in plasma of ovarian and breast cancer patients Int J Cancer 118 2006 412 421
60. M. Bamshad, R.C. Lin, D.J. Law, W.C. Watkins, P.A. Krakowiak, M.E. Moore, P. Franceschini, R. Lala, L.B. Holmes, T.C. Gebuhr, B.G. Bruneau, A. Schinzel, J.G. Seidman, C.E. Seidman, and L.B. Jorde Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome Nat Genet 16 1997 311 315
61. P.A. Havre, M. Rice, R. Ramos, and E.B. Kmiec HsRec2/Rad51L1, a protein influencing cell cycle progression, has protein kinase activity Exp Cell Res 254 2000 33 44
62. A. Shlien, U. Tabori, C.R. Marshall, M. Pienkowska, L. Feuk, A. Novokmet, S. Nanda, H. Druker, S.W. Scherer, and D. Malkin Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome Proc Natl Acad Sci U S A 105 2008 11264 11269
63. N.P. Dantuma, C. Heinen, and D. Hoogstraten The ubiquitin receptor Rad23: at the crossroads of nucleotide excision repair and proteasomal degradation DNA Repair (Amst) 8 2009 449 460
64. I. Murfuni, S. Nicolai, S. Baldari, M. Crescenzi, M. Bignami, A. Franchitto, and P. Pichierri The WRN and MUS81 proteins limit cell death and genome instability following oncogene activation Oncogene 32 2013 610 620
65. P. Castro, H. Liang, J.C. Liang, and L. Nagarajan A novel, evolutionarily conserved gene family with putative sequence-specific single-stranded DNA-binding activity Genomics 80 2002 78 85
66. L. Feng, J. Huang, and J. Chen MERIT40 facilitates BRCA1 localization and DNA damage repair Genes Dev 23 2009 719 728
67. F. Toledo, and G.M. Wahl MDM2 and MDM4: p53 regulators as targets in anticancer therapy Int J Biochem Cell Biol 39 2007 1476 1482
68. A. Kamb, N.A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S.V. Tavtigian, E. Stockert, R.S. Day III, B.E. Johnson, and M.H. Skolnick A cell cycle regulator potentially involved in genesis of many tumor types Science 264 1994 436 440
69. C.E. Caldon, R.J. Daly, R.L. Sutherland, and E.A. Musgrove Cell cycle control in breast cancer cells J Cell Biochem 97 2006 261 274
70. D.T. Wu, M. Bitzer, W. Ju, P. Mundel, and E.P. Bottinger TGF-beta concentration specifies differential signaling profiles of growth arrest/differentiation and apoptosis in podocytes J Am Soc Nephrol 16 2005 3211 3221
71. W. Zhang, and H.T. Liu MAPK signal pathways in the regulation of cell proliferation in mammalian cells Cell Res 12 2002 9 18
72. M. Mongan, J. Wang, H. Liu, Y. Fan, C. Jin, W.Y. Kao, and Y. Xia Loss of MAP3K1 enhances proliferation and apoptosis during retinal development Development 138 2011 4001 4012
73. K.E. Cavdar, A. Ranasinghe, W. Burkhart, K. Blackburn, H. Koc, A. Moseley, and L.L. Spremulli A new face on apoptosis: death-associated protein 3 and PDCD9 are mitochondrial ribosomal proteins FEBS Lett 492 2001 166 170
74. R.C. Sears The life cycle of C-myc: from synthesis to degradation Cell Cycle 3 2004 1133 1137
75. Y.H. Wang, S. Liu, G. Zhang, C.Q. Zhou, H.X. Zhu, X.B. Zhou, L.P. Quan, J.F. Bai, and N.Z. Xu Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo Breast Cancer Res 7 2005 R220 R228
76. S.F. Grant, G. Thorleifsson, I. Reynisdottir, R. Benediktsson, A. Manolescu, J. Sainz, A. Helgason, H. Stefansson, V. Emilsson, A. Helgadottir, U. Styrkarsdottir, K.P. Magnusson, G.B. Walters, E. Palsdottir, T. Jonsdottir, T. Gudmundsdottir, A. Gylfason, J. Saemundsdottir, R.L. Wilensky, M.P. Reilly, D.J. Rader, Y. Bagger, C. Christiansen, V. Gudnason, G. Sigurdsson, U. Thorsteinsdottir, J.R. Gulcher, A. Kong, and K. Stefansson Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes Nat Genet 38 2006 320 323
77. M. Cargnello, and P.P. Roux Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases Microbiol Mol Biol Rev 75 2011 50 83
78. T.R. Kress, I.G. Cannell, A.B. Brenkman, B. Samans, M. Gaestel, P. Roepman, B.M. Burgering, M. Bushell, A. Rosenwald, and M. Eilers The MK5/PRAK kinase and Myc form a negative feedback loop that is disrupted during colorectal tumorigenesis Mol Cell 41 2011 445 457
79. U.M. Fiuza, and A.M. Arias Cell and molecular biology of Notch J Endocrinol 194 2007 459 474
80. C.F. O'Neill, S. Urs, C. Cinelli, A. Lincoln, R.J. Nadeau, R. Leon, J. Toher, C. Mouta-Bellum, R.E. Friesel, and L. Liaw Notch2 signaling induces apoptosis and inhibits human MDA-MB-231 xenograft growth Am J Pathol 171 2007 1023 1036
81. K. Sugimoto, Y. Maekawa, A. Kitamura, J. Nishida, A. Koyanagi, H. Yagita, H. Kojima, S. Chiba, M. Shimada, and K. Yasutomo Notch2 signaling is required for potent antitumor immunity in vivo J Immunol 184 2010 4673 4678
82. D.W. Stacey Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells Curr Opin Cell Biol 15 2003 158 163
83. D.M. Ornitz, and N. Itoh Fibroblast growth factors Genome Biol 2 2001 REVIEWS3005
84. T. Nakamura, T. Nakamura, and K. Matsumoto The functions and possible significance of Kremen as the gatekeeper of Wnt signalling in development and pathology J Cell Mol Med 12 2008 391 408
85. N. Ahmadiyeh, M.M. Pomerantz, C. Grisanzio, P. Herman, L. Jia, V. Almendro, H.H. He, M. Brown, X.S. Liu, M. Davis, J.L. Caswell, C.A. Beckwith, A. Hills, L. Macconaill, G.A. Coetzee, M.M. Regan, and M.L. Freedman 8q24 Prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC Proc Natl Acad Sci U S A 107 2010 9742 9746
86. J. Sotelo, D. Esposito, M.A. Duhagon, K. Banfield, J. Mehalko, H. Liao, R.M. Stephens, T.J. Harris, D.J. Munroe, and X. Wu Long-range enhancers on 8q24 regulate c-Myc Proc Natl Acad Sci U S A 107 2010 3001 3005
87. K.B. Meyer, A.T. Maia, M. O'Reilly, M. Ghoussaini, R. Prathalingam, P. Porter-Gill, S. Ambs, L. Prokunina-Olsson, J. Carroll, and B.A. Ponder A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression PLoS Genet 7 2011 e1002165
88. S. Esseghir, A. Kennedy, P. Seedhar, A. Nerurkar, R. Poulsom, J.S. Reis-Filho, and C.M. Isacke Identification of NTN4, TRA1, and STC2 as prognostic markers in breast cancer in a screen for signal sequence encoding proteins Clin Cancer Res 13 2007 3164 3173
89. H. Liang, Y. Zhong, Y. Huang, and G. Chen Type 1 receptor parathyroid hormone (PTH1R) influences breast cancer cell proliferation and apoptosis induced by high levels of glucose Med Oncol 29 2012 439 445
90. Y. Qiao, X. Jiang, S.T. Lee, R.K. Karuturi, S.C. Hooi, and Q. Yu FOXQ1 regulates epithelial-mesenchymal transition in human cancers Cancer Res 71 2011 3076 3086
91. M.A. Debily, A. Camarca, M. Ciullo, C. Mayer, S. El Marhomy, I. Ba, A. Jalil, A. Anzisi, J. Guardiola, and D. Piatier-Tonneau Expression and molecular characterization of alternative transcripts of the ARHGEF5/TIM oncogene specific for human breast cancer Hum Mol Genet 13 2004 323 334
92. J.C. Lee, M. Sharma, Y.H. Lee, N.H. Lee, S.Y. Kim, J.S. Yun, S.Y. Nam, P.H. Hwang, E.C. Jhee, and H.K. Yi Pax9 mediated cell survival in oral squamous carcinoma cell enhanced by c-myb Cell Biochem Funct 26 2008 892 899
93. S. Muehlich, R. Wang, S.M. Lee, T.C. Lewis, C. Dai, and R. Prywes Serum-induced phosphorylation of the serum response factor coactivator MKL1 by the extracellular signal-regulated kinase 1/2 pathway inhibits its nuclear localization Mol Cell Biol 28 2008 6302 6313
94. K.A. White, M.M. Yore, D. Deng, and M.J. Spinella Limiting effects of RIP140 in estrogen signaling: potential mediation of anti-estrogenic effects of retinoic acid J Biol Chem 280 2005 7829 7835
95. Z. Liu, H. Ma, S. Wei, G. Li, E.M. Sturgis, and Q. Wei Telomere length and TERT functional polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck Cancer Epidemiol Biomarkers Prev 20 2011 2642 2645
96. D.M. Baird Variation at the TERT locus and predisposition for cancer Expert Rev Mol Med 12 2010 e16
97. J.U. Kang, S.H. Koo, K.C. Kwon, J.W. Park, and J.M. Kim Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer Cancer Genet Cytogenet 182 2008 1 11
98. A. Zhang, S. Maner, R. Betz, T. Angstrom, U. Stendahl, F. Bergman, A. Zetterberg, and K.L. Wallin Genetic alterations in cervical carcinomas: frequent low-level amplifications of oncogenes are associated with human papillomavirus infection Int J Cancer 101 2002 427 433
99. M.H. Gail Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk J Natl Cancer Inst 100 2008 1037 1041
100. M.H. Gail Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model J Natl Cancer Inst 101 2009 959 963
101. M. Ghoussaini, and P.D. Pharoah Polygenic susceptibility to breast cancer: current state-of-the-art Future Oncol 5 2009 689 701
102. P.D. Pharoah, A. Antoniou, M. Bobrow, R.L. Zimmern, D.F. Easton, and B.A. Ponder Polygenic susceptibility to breast cancer and implications for prevention Nat Genet 31 2002 33 36
103. N. Pashayan, S.W. Duffy, S. Chowdhury, T. Dent, H. Burton, D.E. Neal, D.F. Easton, R. Eeles, and P. Pharoah Polygenic susceptibility to prostate and breast cancer: implications for personalised screening Br J Cancer 104 2011 1656 1663
104. H. Burton, S. Chowdhury, T. Dent, A. Hall, N. Pashayan, and P. Pharoah Public health implications from COGS and potential for risk stratification and screening Nat Genet 45 2013 349 351